Cargando…
Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
BACKGROUND: Behcet's disease (BD) is a systemic inflammatory disease with the histopathological features of leukocytoclastic vasculitis that affects nearly all organs and systems. When it involves the intestine, it is called entero-Behcet's disease (entero-BD). CASE PRESENTATION: Here we d...
Autores principales: | Li, Yue, Han, Zelong, Wang, Xianfei, Mo, Zhihui, Zhang, Wei, Li, Aimin, Liu, Side |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029173/ https://www.ncbi.nlm.nih.gov/pubmed/24321021 http://dx.doi.org/10.1186/1471-230X-13-167 |
Ejemplares similares
-
Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
por: Katsuyama, Atsuko, et al.
Publicado: (2019) -
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease
por: Miyagawa, Ippei, et al.
Publicado: (2019) -
Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
por: Nakamura, Akihiro, et al.
Publicado: (2016) -
Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease
por: Alfawaz, Abullah, et al.
Publicado: (2014) -
Parallel disease activity of Behçet’s disease with renal and entero involvements: a case report
por: Watanabe-Kusunoki, Kanako, et al.
Publicado: (2021)